default author photo

Mian Xi

Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China

SCHOLARLY PAPERS

3

DOWNLOADS

200

TOTAL CITATIONS

0

Scholarly Papers (3)

Actions:
Email selected abstracts
1.

Progression-Free Survival at 36 Months is a Reliable Surrogate for 5-Year Overall Survival for Patients Suffering From Locally Advanced Esophageal Squamous Cell Carcinoma

Number of pages: 36 Posted: 10 Feb 2022
Yu-Xian Yang, Yu-Zhen Zheng, Tian-Tian Gao, Ze-Wei Zhang, Shi-Liang Liu, Mian Xi, Meng-Zhong Liu, Jun-Ye Wang, Shu-Nan Qi, Yong Yang and Lei Zhao
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Thoracic Surgery, Sun Yat-sen University (SYSU) - Department of Radiation Oncology, Sun Yat-sen University (SYSU) - Department of Radiation Oncology, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - Department of Thoracic Surgery, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Department of Radiation Oncology, Fujian Medical University - Department of Radiation Oncology and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 97 (704,534)

Abstract:

Loading...

Esophageal squamous cell carcinoma, progression-free survival at 36 months, overall survival

2.

Efficacy, Safety, and Biomarkers of Toripalimab Combined with Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II Trial (EC-CRT-001)

Number of pages: 35 Posted: 22 Nov 2022
Yu-Jia Zhu, Jing Wen, Qiaoqiao Li, Lei Zhao, Shi-Liang Liu, Baoqing Chen, Yadi Yang, Sifen Wang, Yingxin Lv, Yong-Hong Hu, Meng-Zhong Liu and Mian Xi
Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China and Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China
Downloads 58 (980,173)

Abstract:

Loading...

Esophageal squamous cell carcinoma, toripalimab, definitive chemoradiotherapy, clinical complete response, survival.

3.

Continuation of First-Line Systemic Therapy with Progression-Directed Radiotherapy in Oligoprogressive Hepatocellular Carcinoma: A Multi-Center, Single-Arm, Phase II Trial

Number of pages: 29 Posted: 04 Nov 2025
Fang Shi, Haohua Wang, Yongjing Yang, Lijuan Ding, Yi Ding, Yuqin Zhang, Mian Xi, Yanli Qu, Zhongjie Chen, Yi Lu, Yongqiang Yang, Luying Liu and Jinbo Yue
Shandong First Medical University - Shandong Cancer Hospital and Institute, Shandong Academy of Medical Sciences, Jilin Cancer Hospital, Jilin University (JLU), Southern Medical University, Southern Medical University, Sun Yat-sen University (SYSU) - State Key Laboratory of Oncology in South China, Dalian University of Technology, Tianjin Medical University, Ningbo University, Soochow University, Zhejiang Cancer Hospital and Shandong First Medical University - Shandong Cancer Hospital and Institute
Downloads 45 (1,121,190)

Abstract:

Loading...

hepatocellular carcinoma, oligoprogression, radiotherapy, first-line systemic therapy